124 related articles for article (PubMed ID: 23652452)
1. Stroke features and management in patients with chronic kidney disease.
Kamouchi M
Contrib Nephrol; 2013; 179():92-9. PubMed ID: 23652452
[TBL] [Abstract][Full Text] [Related]
2. Cerebrorenal interaction and stroke.
Toyoda K
Contrib Nephrol; 2013; 179():1-6. PubMed ID: 23676853
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy for preventing stroke in patients with chronic kidney disease.
Kim SJ; Bang OY
Contrib Nephrol; 2013; 179():119-29. PubMed ID: 23652455
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and stroke.
El Husseini N; Kaskar O; Goldstein LB
Adv Chronic Kidney Dis; 2014 Nov; 21(6):500-8. PubMed ID: 25443575
[TBL] [Abstract][Full Text] [Related]
5. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
6. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Ahmad Y; Lip GY
Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
[TBL] [Abstract][Full Text] [Related]
7. Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke.
Lee JG; Lee KB; Jang IM; Roh H; Ahn MY; Woo HY; Hwang HW
Cerebrovasc Dis; 2013; 35(1):53-9. PubMed ID: 23428997
[TBL] [Abstract][Full Text] [Related]
8. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
[TBL] [Abstract][Full Text] [Related]
9. Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population.
Holzmann MJ; Aastveit A; Hammar N; Jungner I; Walldius G; Holme I
Ann Med; 2012 Sep; 44(6):607-15. PubMed ID: 21612332
[TBL] [Abstract][Full Text] [Related]
10. In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke.
Agrawal V; Rai B; Fellows J; McCullough PA
Nephrol Dial Transplant; 2010 Apr; 25(4):1150-7. PubMed ID: 19945951
[TBL] [Abstract][Full Text] [Related]
11. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
[TBL] [Abstract][Full Text] [Related]
12. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease.
Ovbiagele B; Sanossian N; Liebeskind DS; Kim D; Ali LK; Pineda S; Saver JL
Cerebrovasc Dis; 2009; 28(6):582-8. PubMed ID: 19844098
[TBL] [Abstract][Full Text] [Related]
13. A Narrative Review on Thrombolytics in Advanced CKD: Is it an Evidence-Based Therapy?
Burlacu A; Artene B; Covic A
Cardiovasc Drugs Ther; 2018 Oct; 32(5):463-475. PubMed ID: 30187347
[TBL] [Abstract][Full Text] [Related]
14. Proteinuria and clinical outcomes after ischemic stroke.
Kumai Y; Kamouchi M; Hata J; Ago T; Kitayama J; Nakane H; Sugimori H; Kitazono T;
Neurology; 2012 Jun; 78(24):1909-15. PubMed ID: 22592359
[TBL] [Abstract][Full Text] [Related]
15. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
[TBL] [Abstract][Full Text] [Related]
16. Management of atrial fibrillation in chronic kidney disease: double trouble.
Nimmo C; Wright M; Goldsmith D
Am Heart J; 2013 Aug; 166(2):230-9. PubMed ID: 23895805
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment.
Najafi I; Shakeri R; Islami F; Malekzadeh F; Salahi R; Yapan-Gharavi M; Hosseini M; Hakemi M; Alatab S; Rahmati A; Broumand B; Nobakht-Haghighi A; Larijani B; Malekzadeh R
Arch Iran Med; 2012 Feb; 15(2):70-5. PubMed ID: 22292573
[TBL] [Abstract][Full Text] [Related]
18. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
20. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation.
Pieri A; Lopes TO; Gabbai AA
Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
